Assessing the Induction of Long-term Immune Regulation Following Treatment With Lemtrada® (Alemtuzumab).

Stopped Study funding was terminated.

Conditions

• Multiple Sclerosis

Interventions

• OTHER: Assessment of leukocyte function.

Sponsor

University of Southern California